Greenville, NORTH%20CAROLINA2 Active Studies

Ulcerative Colitis Clinical Trials in Greenville, NORTH%20CAROLINA

Find 2 actively recruiting ulcerative colitis clinical trials in Greenville, NORTH%20CAROLINA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
160
Enrolling

Recruiting Ulcerative Colitis Studies in Greenville

About Ulcerative Colitis Clinical Trials in Greenville

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 2 ulcerative colitis clinical trials recruiting participants in Greenville, NORTH%20CAROLINA. These studies are seeking a combined 160 participants. Research is being sponsored by Mirador Therapeutics, Inc., Bausch Health Americas, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in Greenville — FAQ

Are there ulcerative colitis clinical trials in Greenville?

Yes, there are 2 ulcerative colitis clinical trials currently recruiting in Greenville, NORTH%20CAROLINA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Greenville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Greenville research site will contact you about next steps.

Are clinical trials in Greenville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Greenville studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 2 active trials in Greenville are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated March 2, 2026 from ClinicalTrials.gov